Concr

AI platform for biopharma and researchers to assess oncology drug response using sparse preclinical and clinical data

London, United KingdomFounded 2018concr.coWebsite technologies

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-11-05

About Concr

Concr develops FarrSight, a Bayesian AI platform that turns sparse preclinical and clinical data into explainable, confidence-scored evidence for oncology drug development. Its tools support predictive analytics, bioinformatics and data management.

The company works with biopharma partners and scientific researchers on drug development and clinical research. FarrSight can simulate drug response from preclinical models to patients and estimate benefit for trial participants.

Concr Ltd was founded in 2018 and is headquartered in London. It presents hubs in Cambridge, UK, and Brisbane, Australia.

Product: FarrSight, an AI platform for oncology drug-response prediction, bioinformatics and data management.

Jobs at Concr

No open positions listed right now.

Leadership

More biotech & pharma companies

  • Constant Systems

    Cell disruption and lysis equipment for life-science and structural biology labs and large-scale homogenization processes
    Daventry, United KingdomBiotech & pharmaFounded 1989
    New on Evolc
  • Constructivebio

    Designs and manufactures new-to-nature proteins and peptides for pharmaceutical and industrial partners
    United KingdomBiotech & pharma2 open jobs
    New on Evolc
  • Cormica

    Accredited testing services for pharmaceutical, medical device and combination product manufacturers
    London, United KingdomBiotech & pharmaFounded 2021
    New on Evolc
  • Crescent Pharma

    Develops, manufactures and supplies generic medicines to healthcare providers and pharmaceutical channels in the UK
    Basingstoke, United KingdomBiotech & pharmaFounded 2003
    New on Evolc
  • Curaleaf International

    Medical cannabis cultivation, manufacturing and distribution for patients, clinics and pharmacies in Europe and beyond
    London, United KingdomBiotech & pharmaFounded 2018
    New on Evolc
  • Cureage Therapeutics

    Develops genetic therapies for people with peripheral nerve diseases, starting with NF1
    London, United KingdomBiotech & pharmaFounded 2024
    Young companyNew on Evolc

All biotech & pharma companies →

Website technologies

Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.

Content management

Hosting

Recruiting

  • BambooHRMedium confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.